311 filings
6-K
BNTX
BioNTech SE
10 Jan 23
Current report (foreign)
4:04pm
6-K
BNTX
BioNTech SE
10 Jan 23
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
9:07am
6-K
BNTX
BioNTech SE
22 Dec 22
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
8:03am
6-K
BNTX
BioNTech SE
9 Dec 22
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation
9:17am
6-K
BNTX
BioNTech SE
8 Dec 22
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
5:27pm
6-K
BNTX
BioNTech SE
7 Dec 22
Current report (foreign)
5:39pm
6-K
BNTX
BioNTech SE
5 Dec 22
Current report (foreign)
8:48am
6-K
BNTX
BioNTech SE
30 Nov 22
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
7:51am
6-K
BNTX
BioNTech SE
18 Nov 22
Current report (foreign)
7:43am
6-K
BNTX
BioNTech SE
16 Nov 22
Current report (foreign)
9:56pm
6-K
BNTX
BioNTech SE
10 Nov 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster
4:33pm
6-K
BNTX
BioNTech SE
10 Nov 22
Current report (foreign)
4:32pm
6-K
BNTX
BioNTech SE
7 Nov 22
Unaudited Interim Condensed Consolidated Financial Statements
6:24am
6-K
BNTX
BioNTech SE
7 Nov 22
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
6:07am
6-K
BNTX
BioNTech SE
4 Nov 22
Current report (foreign)
5:00pm
20-F/A
2021 FY
BNTX
BioNTech SE
26 Oct 22
Annual report (foreign) (amended)
5:20pm
6-K
BNTX
BioNTech SE
19 Oct 22
Current report (foreign)
6:27pm
6-K
BNTX
BioNTech SE
13 Oct 22
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
5:58pm
6-K
BNTX
BioNTech SE
12 Oct 22
Current report (foreign)
5:17pm
6-K
BNTX
BioNTech SE
26 Sep 22
Current report (foreign)
7:18am